Search For "gilead sciences inc"
Gilead to give licensees in India support to open more Remdesivir manuf
Updated : 4 years, 10 months ago IST
California [US], April 29 (ANI/Sputnik): US-based Gilead Sciences Inc company, the developer of antiviral drug Remdesivir, used for treatment of COVID-19 patients, will provide all its licensing partners in coronavirus-hit India with the technical support for the addition of new manufacturin
Read More
US FDA approves remdesivir, first drug to treat COVID-19 patients
Updated : 5 years, 4 months ago IST
Washington [US], October 23 (ANI): The United States Food and Drug Administration (FDA) has approved Remdesivir for the treatment of coronavirus, Al Jazeera reported citing a statement issued by Gilead Sciences, Inc.
Read More
Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment
Updated : 5 years, 6 months ago IST
Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.
Read More
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Updated : 5 years, 7 months ago IST
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Read More
Jubilant launches Remdesivir in India for treatment of COVID-19
Updated : 5 years, 7 months ago IST
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Read More
Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesivir
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], June 13 (ANI): Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc that will grant Dr Reddy's the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potent
Read More
Zydus signs licensing agreement with Gilead to manufacture and market Remd
Updated : 5 years, 9 months ago IST
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
Read More
Jubilant Life Sciences surges 5 pc after signing deal with Gilead for prod
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.
Read More
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Read More
Tata Trusts, Gilead sign MoU to address viral hepatitis in India
Updated : 8 years, 6 months ago IST
New Delhi, Aug 4 (ANI): Tata Trusts and Gilead Sciences, Inc. today signed a Memorandum of Understanding (MoU) under the presence of Chairman Tata Trusts, Ratan Tata to explore collaborating within India on an initiative to address the burden of viral hepatitis in the country.
Read More